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Abstract Cancer is a complex phenomenon, and the sheer variation in behaviour
across different types renders it difficult to ascertain underlying biological mecha-
nisms. Experimental approaches frequently yield conflicting results for myriad rea-
sons, and mathematical modelling of cancer is a vital tool to explore what we cannot
readily measure, and ultimately improve treatment and prognosis. Like experiments,
models are underpinned by certain biological assumptions, variation of which can
lead to divergent predictions. An outstanding and important question concerns Con-
tact Inhibition of Proliferation (CIP), the observation that proliferation ceases when
cells are spatially confined by their neighbors. CIP is a characteristic of many healthy
adult tissues, but it remains unclear to which extent it holds in solid tumours, which
exhibit regions of hyper-proliferation, and apparent breakdown of CIP. What pre-
cisely occurs in tumour tissue remains an open question, which mathematical mod-
elling can help shed light on. In this perspective piece, we explore the implications
of different hypotheses and available experimental evidence to elucidate the implica-
tions of these scenarios. We also outline how erroneous conclusions about the nature
of tumour growth may be arrived at by looking selectively at biological data in isola-
tion, and how this might be circumvented.
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1 Introduction
Cancer is a deeply complex phenomenon, and mathematical modelling has become a
powerful and increasingly important tool in cancer research (Byrne, 2010; Anderson
and Quaranta, 2008). It provides an in silico laboratory in which to investigate hy-
pothesized mechanisms of cancer progression and predict the response to different in-
terventions. Mathematical models can readily inform in vivo and in vitro experiments
and predict previously unseen behaviour. Equally, they can be informed by biological
data to yield more robust conclusions. Used correctly, modelling can both identify
interesting avenues for future research and streamline the design of new experiments,
thus contributing to the 3Rs principles of animal experimentation (replacement, re-
finement and reduction). Mathematical modelling of solid tumour growth has long
been an area of interest, and a multitude of mathematical models derived to capture
different aspects of tumour growth (Gerlee, 2013), including heterogeneity, treatment
response and interactions with host tissues.
Yet models, like experiments, are underpinned by assumptions. There is emerging
biological data that suggests cells in two-dimensional configurations behave markedly
differently than those in 3D aggregates (Pickl and Ries, 2009; Kunz-Schughart et al.,
2000; Edmondson et al., 2014; Imamura et al., 2015; Riedl et al., 2016; Stock et al.,
2016). Accordingly, model assumptions that are suitable for healthy tissue or a par-
ticular cancer type may not be applicable in other circumstances. It is important also
to distinguish between a phenomenological description, whose parameters may have
no direct physical correlate, and a mechanistic model that seeks to describe the un-
derlying physical processes (Tracqui, 2009; Araujo and McElwain, 2004).
Conflicting experimental findings are common too, and accordingly interpreta-
tion and extrapolation of experimental results is also fraught with difficulty. Solid
tumour growth dynamics illustrate this point well. Historically, tumour growth has
been described by sigmoidal functions, including the von Bertalanffy, Gompertzian
and logistic family of models (Steel, 1977; Wheldon, 1988; Vaidya and Alexandro,
1982). In these models, growth is initially unrestrained, before becoming limited by
depletion of essential nutrients such as oxygen, with approximately sigmoidal func-
tions generally thought of as adequate to describe general avascular growth (Feller,
1940; Gyllenberg and Webb, 1988; Marusˇic´ et al., 1994). On the other hand, it has
been suggested based on colony evidence that tumour growth is not limited by nutri-
ent availability, but by spatial constraints (Bru´ et al., 2003), such that tumour radius
grows linearly with time, and is restricted to the periphery. This claim remains con-
troversial (Buceta and Galeano, 2005), but serves as a prominent example of conflict-
ing claims in the literature. In addition, there is often unavoidable ambiguity in
available biological data, which may be of unclear provenance. This can result
in situations where biological data may be incorrectly interpreted as providing
evidence in support of a modelling prediction when this may not be the case.
Biologically, these divergent views can be recast as a question of whether cancers
in general remain subject to contact inhibition of proliferation (CIP). In healthy tis-
sues, cell proliferation is inhibited as a result of cell-cell contact (Nelson and Chen,
2002; Holley and Kiernan, 1968; Harry and Levine, 1967). While precise mecha-
nisms are not yet fully understood, the signaling pathways underlying CIP in adult
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tissues are starting to be elucidated (Ku¨ppers et al., 2010), with evidence for the in-
volvement of the rapamycin (Leontieva et al., 2014) and hippo pathways (Zeng and
Hong, 2008). This suggests that only cells on the tissue periphery can undergo mi-
tosis. However, hyper-proliferation is a hallmark of cancer (Hanahan and Weinberg,
2000) and it is important to probe potential reasons for this. There is experimental ev-
idence for failure of normal CIP mechanisms in human cancers (Levine et al., 1965;
Kim et al., 2004; Lloyd et al., 1999; Leontieva and Blagosklonny, 2011; McClatchey
and Yap, 2012), while studies on the naked mole rat have suggested that the animal’s
remarkable apparent immunity to cancer may be related to its hyper-sensitivity to
cell-cell inhibition (Seluanov et al., 2009). This suggests that CIP is greatly reduced
or absent in many solid tumours. In these cases, cells that would normally be unable
to proliferate in healthy tissue due to their spatial location become able to undergo
mitosis.
This is an important consideration, as spatial localization of proliferation affects
our predictions on tumour growth and response to treatment. Precisely what is oc-
curring remains unclear, but here we argue that mathematical models can shed
some light on predicted behaviour, demonstrating that CIP is a good example
of an instance where modelling can help resolve debates in biology. Here, we
probe the predictions and implications of both paradigms in 2D plated cells and 3D
avascular tumours. The impact of these different assumptions are simulated, and com-
pared with experimental data. The biological and modelling implications stemming
from this analysis are discussed, and future avenues to better elucidate the problem
explored.
2 Methods
2.1 Analysis of 2D plated cell growth
Plated cell monolayers remain the simplest way to examine cell growth in vitro, with
no nutrient heterogeneity so that all cells receive ample glucose and oxygen. Under
the assumption of CIP, only cells at the edge of a cell colony proliferate. Assuming
an average cell diameter of L, average doubling time td and initial colony radius of
r0, the area ac of a circular colony under CIP therefore grows quadratically with time
t:
ac(t) = pi
(
r0+
Lt
td
)2
. (1)
Without the constraint of CIP, the area instead grows exponentially:
au(t) = (pir
2
o)2
t/td . (2)
The growth dynamics predicted for 2D plated cell colonies are not especially use-
ful for gaining insight into three-dimensional tumour growth, given their implicit
assumption of nutrient homogeneity. Even so, it is important to quantify potential
differences that would be expected in growth dynamics with or without CIP.
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2.2 Analysis of 3D avascular tumour growth
Multicellular tumour spheroids are the simplest of 3D cellular aggregates, extensively
employed to study tumour growth dynamics, as their growth dynamics more closely
resemble those of in situ tumours than do monolayer cultures. Such assays have been
widely used in experimental and modelling studies (Hirschhaeuser et al., 2010). As
spheroids grow, central regions become devoid of essential nutrients such as oxygen,
and as a consequence tumour spheroids develop regions of central hypoxia and even-
tually necrosis, just as in avascular tumours. The extent of central necrosis and the
oxygen distribution throughout the spheroid depend upon the oxygen consumption
rate of the cell line in question (Grimes et al., 2014b,a).
Growth dynamics for multicellular tumour spheroids have been well studied (Con-
ger and Ziskin, 1983; Freyer, 1988; Grimes et al., 2016). Evidence suggests that
spheroids exhibit a classical sigmoidal growth profile. Conger and Zisikin(Conger
and Ziskin, 1983) examined spheroid growth over multiple cell lines, finding that
spheroids have an initial exponential growth phase, followed by a quasi-linear phase
where limited nutrient diffusion inhibits growth, and finally a plateau phase. Such dy-
namics are similar to growth curves exhibited by solid tumours in situ (Steel, 1977;
Conger and Ziskin, 1983; Gyllenberg and Webb, 1988; Grimes et al., 2016). The
Gompertzian model captures tumour growth dynamics especially well, but can lead
to unrealistically slow growth in initial phrases. Wheldon (Wheldon, 1988) proposed
a Hybrid ‘Gomp-ex’ model to better capture early growth behaviour, also reflected in
tumour growth dynamics (Benzekry et al., 2014).
Multicellular tumour spheroids present an excellent test-bed for examining CIP
assumptions. Broadly speaking, there are two possible scenarios: if we assume that
CIP is in effect, then for a initial small spheroid only cells on the outermost layer
proliferate, whilst those inside the central mass are inhibited from mitosis. Assuming
spherical symmetry, if cells have an average diameter L and average doubling time
td , then the change in radius over time is given by dr/dt = L/td . Defining the initial
radius to be r0, we find that the spheroid radius is given by r(t) = r0+Lt/td , and thus
its volume Vc(t) is given by
Vc(t) =
4pi
3
(
r0+
Lt
td
)3
. (3)
Thus, under CIP assumptions, a cubic growth rate essentially agnostic to the inter-
nal nutrient distribution is expected, with cells on the external border continuing to
grow (Bru´ et al., 2003).
In contrast, if we assume CIP is defective in tumour cells, then any cell with
enough nutrients will attempt to undergo mitosis. For spheroids grown in vitro, glu-
cose levels are high throughout and oxygen availability is usually the limiting fac-
tor (Hirschhaeuser et al., 2010; Grimes et al., 2014b). There are various avascular
growth models which can be employed to describe this (Roose et al., 2007); for sim-
plicity, we take a simple recursive model that explicitly relates spheroid growth to
nutrient availability (Grimes et al., 2014a). In this schema, the spheroid volume Vu at
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time-step N +1 is given by
(Vu)N+1 =
4pi
3
(
2r3N − (rp)
3
N − (rn)
3
N
)
, (4)
where rN and (rn)N are the spheroid radius and necrotic radius at time-step N, re-
spectively, and (rp)N is the radius below which the oxygen partial pressure p drops
below the level required for mitosis, pm. In practice, cells can undergo mitosis at even
very low oxygen partial pressures, and typically pm ≈ 0.5 mmHg (Hockel and Vau-
pel, 2001). All these radii can be analytically calculated from first principles knowing
cellular oxygen consumption rate, with details omitted here for brevity(Grimes et al.,
2016). In the case of unlimited nutrient diffusion, rn = rp = 0, and growth is expo-
nential.
2.3 Model comparisons with experimental data
2D monolayers For 2D growth, we simulate a simple cellular automaton model of
tumour growth using Chaste (Osborne et al., 2017), an open-source C++ library for
agent-based simulation of cell populations. Further details of the simulations are pro-
vided below.
In this model, cell movement is driven by division and cell exchange, using a
shoving-based approach (Yates et al., 2015). The spatial domain is discretised into a
regular square lattice with cells occupying the individual lattice sites. The area Ai of
each cell i in this model is given by 1 squared cell diameter (CD2). Cell proliferation
proceeds as follows; A dividing cell selects a random lattice site from its Moore
neighbourhood (the eight cells that surround it), and all cells along the row, column
or diagonal from the dividing cell’s location are instantaneously displaced or ‘shoved’
to make space for the new cell.
A Metropolis-Hastings algorithm is used to make additional updates to the state
of the tissue using asynchronous updating. At each time step ∆ t, after checking for
and implementing any cell divisions, we sample with replacement NC cells, where
NC is the number of cells in the tissue at time t (thus, it may be the case that a
cell is sampled more than once in a time step, while others are not sampled). This
sweeping of the domain is also known as a Monte Carlo Step (MCS). We randomly
select a neighbouring lattice site from each sampled cell’s Moore neighbourhood for
a potential swap. The swapping of cells is intended to model random motility and the
affinity of cells to form and break connections with adjacent cells. Assigning theMCS
to a time step ∆ t allows us to parametrize the timescale of the switching process and
relate this to cell division. A probability per hour is assigned for the cells (or empty
lattice site, which we refer to as a void) to swap locations, pswap, which is calculated
as
pswap =
{
κswap, for ∆H ≤ 0,
κswap exp
(
−
∆H
T
)
, for ∆H > 0.
(5)
where κswap represents the rate of switching and T represents the background level of
cell switching, modelling random cell fluctuations. If T = 0 then only energetically
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favourable swaps happen, and we use this as the default value for our simulations;
as T increases, more energetically unfavourable swaps occur. Finally, ∆H = H1−H0
denotes the change in adhesive energy due to the swap, with H0 and H1 being the
energy in the original and changed configurations respectively, which is defined to be
the sum of the adhesion energy between lattice sites:
H = ∑
(i, j)∈N
γ(τ(i),τ( j)), (6)
where γ(a,b) is a constant whose value depends on a and b, representing the adhesion
energy between cells (or void) of type a and b, τ(k) is the type of cell k (or void if
there is no cell on the lattice site) and N is the set of all neighbouring lattice sites.
Here τ(k) takes the values ‘A’, ‘B’ and ‘void’, but can in principle be extended to
more cell types.
In the 2D monolayer case, cell growth was simulated with and without CIP. To
capture CIP failure, the cell-pushing was enabled, whereby cells to push their neigh-
bors during mitosis. Resultant growth curves were obtained, and compared to the
analytic growth curves given by equations (1)–(2) and to the literature. Outputs of
these models were then compared with data from the experimental literature to
ascertain which model most faithfully reproduced observed dynamics.
3D avascular tumour spheroids We can readily investigate predictions for 3D tumour
growth dynamics with and without CIP by analyzing spheroid growth curves. Growth
curves were generated analytically through the forms outlined in equations (3)–(4),
and these simulated spheroid growth curves was compared to previously published
long-range data (over 60 days) (Freyer, 1988; Marusˇic´ et al., 1994; Grimes et al.,
2016) to ascertain model best fits under both assumptions. These growth dynamics
are useful but they do not strictly answer the question of where proliferating cells are
located in situ. To probe this directly, we interrogated histological specimens stained
with Ki-67, a proliferative marker (Scholzen and Gerdes, 2000). We looked at stained
sections from tumour spheroid cross-sections, which are broadly radially symmetric
and relatively easy to interpret.
3 Results
3.1 2D monolayers
As illustrated in Figure 1, Chaste simulations without pushing (corresponding to a
CIP assumption) produced quadratic polynomial fits in strong agreement with an-
alytical form in equation (3). By contrast, allowing pushing produced solutions in
agreement with the no CIP analytical model, which yields exponential growth as pre-
dicted by equation (4). This latter scenario agrees with the bulk of published literature
of 2D monolayers, where exponential growth is typically observed (Demicheli et al.,
1989; Sutherland et al., 1983; Erlichman and Vidgen, 1984; Wheldon, 1988; Steel,
1977).
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Fig. 1 Chaste data (average and standard deviations obtained from 500 runs) with pushing (CIP-failure)
and without (CIP). In for former case, the exponential form in equation (4) fits perfectly with R2 = 1. In
the latter, the polynomial expression in equation (3) fits with R2 > 0.99.
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Fig. 2 Best-fit growth curves for analytical models relative to tumour spheroid data (Freyer, 1988) as-
suming either CIP (space-limited) or no CIP (nutrient limited) scenarios. The assumption of CIP yielded
a best-fit with a negative coefficient of determination (L/td = 2.314× 10
−5 m/day), indicating this does
not describe the data at all. By contrast the mechanistic model assuming no CIP yielded excellent fit
(R2 = 0.9939) with parameters that were biologically realistic.
3.2 3D avascular tumour spheroids
For the available long-range spheroid data, best-fit parameters were found for both
CIP and no CIP assumptions. Best fit parameter values are given in Figure 2, illus-
trated with results. Assuming CIP in this instance yields a negative coefficient of
determination, which means the fit was worse than merely fitting the mean. This
strongly suggests such a model in inadequate to describe the growth data. By con-
trast, the no CIP assumption fitted the data well (R2 = 0.9939) and yielded biolog-
ically realistic values for oxygen consumption rate (a = 6.87 mmHg) and cellular
doubling time td = 2.18 days. As similar patterns of growth are seen throughout
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spheroid derived from many different cell-lines (Conger and Ziskin, 1983; Wheldon,
1988; Marusˇic´ et al., 1994; Grimes et al., 2016), this suggests that CIP in inhibited
in these cell lines, and that growth is not restricted to the outermost extremities. Pre-
viously published data-sets from sectioned and stained tumour DLD-1(Grimes et al.,
2014b) and HCT-116 (Grimes et al., 2016) tumour spheroids were analyzed to deter-
mine the extent of Ki-67 staining. Figure 3 depicts sectioned some of these tumour
spheroids stained with Ki-67 proliferation marker - in all cases, evidence of mitosis
is seen throughout the spheroids, and not solely at the boundaries. This strongly sug-
gests that CIP is absent from these spheroids. In principle, the model outlined in
equation (4) could serve to model both CIP and no CIP assumptions, where the
proliferation radius rp would be markedly reduced. This would then produce
curves with similarly implausible biological parameter values. Equation (3) has
been presented to explicitly depict the CIP scenario. Strictly speaking, this is al-
ways a simplification, as there will always been some diffusion limit where the
growth will be ultimately saturated (Bodnar and Forys´, 2007), and thus infinite
growth would never be observed.
Fig. 3 (A) HCT-116 tumour spheroid stained with Ki-67 (green), a marker of proliferation grown for
4 days (B) The same spheroid co-stained with the hypoxia marker EF5 (red). Proliferation is apparent
throughout the entirety of the spheroid, while there is no central region of anoxia. Images reproduced with
permission (Grimes et al., 2016). (C) Dual-stained DLD-1 tumour spheroid with central necrosis showing
Ki-67 (green) and EF5 (red) grown for 12 days. Proliferation occurs throughout the viable rim. Reproduced
with permission (Grimes et al., 2014b).
4 Discussion
The assumption that only cells on the periphery undergo mitosis seems to be con-
tradicted by experimentally derived growth curves, with histological data suggesting
that mitotic activity occurring in the tumour mass itself too. Even so, we must be
careful not to overstate the generality of these conclusions, as it is entirely possible
that different cell-lines have varying extents of CIP. In some immortalized cell lines,
for example, CIP may still occur despite these cells having the ability to proliferate
indefinitely (Abercrombie, 1979). As the precise mechanisms for CIP are not fully
understood, further experimental evidence will be vital in illuminating this area.
In addition, there are some important caveats to this conclusion, and avenues for
further research. Whilst the evidence presented here suggests cellular proliferation is
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not solely limited to the edge of a tumour or colony, one thing not considered thus
far is the mechanical constraints on a neoplasm. In general, tumours are physically
constrained to a position inside the body. A tumour growing in situ might not have
contact inhibition, but instead might be eventually be physically limited due to hard
boundaries in the form of tissue or organs. This would manifest especially in tissue
resilient to deformation, including bone (Araujo et al., 2014).
More importantly perhaps, even with CIP-inhibition cells cannot ‘infinitely push’
- while all cells with sufficient nutrients and clonogenic capacity might be able to
undergo mitosis, there is likely a point where the surrounding density of cells is so
high that mechanical pressures alone arrest the cell’s mitotic phase and force it into
quiescence. In healthy animal cells, forces > 100nN were sufficient to impinge on
microtubule spindle function and thereby inhibit mitotic progression (Cattin et al.,
2015), with similar trends seen in mechanically compressed spheroids (Desmaison
et al., 2013).When tumour growth is limited by mechanical forces acting on the cells
and effectively constrained, then a phenomenological treatment of this as equivalent
to CIP to capture the behaviour of the system seems an appropriate assumption. The
interpretation of such models will then depend on whether the parameters within are
considered biologically realistic or are intended to explore specific phenomena.
In real settings of course, tumours do not simply grow into empty space, but
within a tissue. As a result, a form of CIP likely takes place at the tumour pe-
riphery, the effects of which are not considered in the simple models discussed
in this work. There are other potentially obscuring factors in real tumours; for
example, some tumours might exhibit high cellular turnover rates, and even if
tumours did display relatively high levels of CIP, the density would still on aver-
age be lower, and proliferation less inhibited. Conversely, if cell death was high,
then proliferation might still be seen in stained sections even if CIP was intact.
These are certainly worthwhile questions beyond the scope of this work, and
ones that require combined clinical/experimental and theoretical investigation
to adequately probe.
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Fig. 4 (a) Long-range growth data for V-79 hamster cells taken from Freyer et al (Freyer, 1988), depicted
with a linear fit through the quasi-linear growth phase with R2 > 0.96 (b) Simulated growth of a DLD-1
tumour spheroid using a mechanistic growth model (Grimes et al., 2016), with a linear fit of R2 > 0.99
through the quasi-linear phase.
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It is worth noting the conflict between Bru´’s paradigm (Bru´ et al., 2003) for linear
’universal’ tumour growth versus the sigmoidal growth more typically reported by
investigators. There are many reasons why these results may be in conflict - firstly, it
is a reality that experimental data is notoriously difficult to replicate. Cancer research
is complicated by the sheer number of confounding factors possible, and similar ex-
periments done in different labs can yield entirely different results for reasons not
entirely understood. It’s worth noting that most of the experimental results in this
work were derived from 2D culture, and thus may not extrapolate to 3D, although
in general 2D culture growth curves are not linear. Whilst growth curves in 3D are
not generally linear, there might be a further way to explain the discrepancy. There
is a substantial region where growth is effectively linear, known as the quasi-linear
growth phase (Conger and Ziskin, 1983). Measurements taken in this regime will
suggest an effectively linear rate of growth, and occur in all sigmoidal models. This
is illustrated in Figure 4 for both biological data and simulated mechanistic growth.
The data and analysis presented here suggests that CIP is in general a casualty of
oncogenesis, and potentially a target for future therapy. The extent to which this is
generalizable remains unanswered, and to truly discover the underlying physical
mechanisms shaping growth dynamics will demand a much more comprehen-
sive synthesis of experimental data with modelling approaches. We believe that
combined clinical/experimental and theoretical approaches (Anderson and Quaranta,
2008) hold the greatest chance of unravelling this mystery. Answering this question
will improving our understanding of how cancer perpetuates,and potentially yield
new insights into how we combat it.
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